Stock Events

Stock Events

Whitehawk Therapeutics 

$4.2
40
+$0.04+0.94% Tuesday 19:54

Statistics

Day High
4.27
Day Low
4.12
52W High
4.24
52W Low
1.58
Volume
112,535
Avg. Volume
-
Mkt Cap
198.14M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.76
0.1
0.97
1.83
Expected EPS
-0.3575
Actual EPS
N/A

Financials

-245.13%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
51.97MRevenue
-127.38MNet Income

Analyst Ratings

7.5Average Price Target
The highest estimate is 8.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WHWK. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Array Technologies
ARRY
Mkt Cap1.2B
Array BioPharma, acquired by Pfizer, focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat cancer, directly competing with Aadi Bioscience.
AMGEN
AMGN
Mkt Cap178B
Amgen has a broad portfolio of treatments, including for cancer, and its focus on innovative therapies makes it a competitor in the oncology space where Aadi Bioscience operates.
Exelixis
EXEL
Mkt Cap11.1B
Exelixis is focused on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers, competing with Aadi Bioscience's niche.
Incyte
INCY
Mkt Cap19.36B
Incyte Corporation has a strong focus on oncology, including targeted cancer therapies, making it a direct competitor to Aadi Bioscience.
Novartis
NVS
Mkt Cap279.67B
Novartis is a large pharmaceutical company with a significant investment in developing treatments for various cancers, including targeted therapies that compete with Aadi Bioscience.
Pfizer
PFE
Mkt Cap149.77B
Pfizer has a diverse oncology portfolio, including targeted therapies and precision medicine, making it a competitor in the same field as Aadi Bioscience.

About

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Show more...
CEO
Dr. David J. Lennon Ph.D.
Employees
40
Country
United States
ISIN
US00032Q1040

Listings

XNAS
US
WHWK
MU
DE
3350.MU
F
DE
3350.F
STU
DE
3350.STU

0 Comments

Share your thoughts

FAQ

What is Whitehawk Therapeutics stock price today?▼
The current price of WHWK is $4.2 USD — it has increased by +0.94% in the past 24 hours. Watch Whitehawk Therapeutics stock price performance more closely on the chart.
What is Whitehawk Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Whitehawk Therapeutics stocks are traded under the ticker WHWK.
Is Whitehawk Therapeutics stock price growing?▼
WHWK stock has risen by +4.33% compared to the previous week, the month change is a +20.12% rise, over the last year Whitehawk Therapeutics has showed a +166.09% increase.
What is Whitehawk Therapeutics market cap?▼
Today Whitehawk Therapeutics has the market capitalization of 198.14M
When is the next Whitehawk Therapeutics earnings date?▼
Whitehawk Therapeutics is going to release the next earnings report on May 07, 2026.
What were Whitehawk Therapeutics earnings last quarter?▼
WHWK earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.48 USD resulting in a +29.55% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Whitehawk Therapeutics revenue for the last year?▼
Whitehawk Therapeutics revenue for the last year amounts to 51.97M USD.
What is Whitehawk Therapeutics net income for the last year?▼
WHWK net income for the last year is -127.38M USD.
How many employees does Whitehawk Therapeutics have?▼
As of May 06, 2026, the company has 40 employees.
In which sector is Whitehawk Therapeutics located?▼
Whitehawk Therapeutics operates in the Health & Wellness sector.
When did Whitehawk Therapeutics complete a stock split?▼
The last stock split for Whitehawk Therapeutics was on August 27, 2021 with a ratio of 1:15.
Where is Whitehawk Therapeutics headquartered?▼
Whitehawk Therapeutics is headquartered in Morristown, United States.